Commerce Bank Reduces Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Commerce Bank decreased its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 57.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,342 shares of the medical instruments supplier's stock after selling 1,797 shares during the period. Commerce Bank's holdings in Mettler-Toledo International were worth $1,642,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after acquiring an additional 28,478 shares during the period. M&T Bank Corp lifted its holdings in Mettler-Toledo International by 14.3% during the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock valued at $7,387,000 after purchasing an additional 615 shares during the last quarter. Allworth Financial LP boosted its position in Mettler-Toledo International by 367.4% during the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after purchasing an additional 169 shares during the period. Nordea Investment Management AB increased its stake in shares of Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock worth $129,919,000 after purchasing an additional 24,285 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in shares of Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after purchasing an additional 5,234 shares during the period. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD traded down $12.48 on Friday, hitting $1,062.52. The company's stock had a trading volume of 165,723 shares, compared to its average volume of 142,983. The company has a market capitalization of $22.14 billion, a PE ratio of 26.22, a PEG ratio of 3.30 and a beta of 1.28. The company has a 50-day simple moving average of $1,164.25 and a 200 day simple moving average of $1,249.32. Mettler-Toledo International Inc. has a 1 year low of $946.69 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, equities research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on MTD shares. Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a report on Monday, February 10th. Finally, Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a report on Monday, April 7th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of "Hold" and an average target price of $1,304.25.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company's stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company's stock, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.